Arrowhead Pharmaceuticals, Inc. - Common Stock (NQ:ARWR)

The Nasdaq 100 closed higher by around 0.2% on Wednesday. Investors, meanwhile, focused on some notable insider trades.

NetApp, Zoom Video And 2 Other Stocks Insiders Are Selling ↗

April 04, 2024

Via Benzinga

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

April 01, 2024

Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data

March 25, 2024

With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.

Cracking The Code: Understanding Analyst Reviews For Arrowhead Pharma ↗

February 07, 2024

Via Benzinga

Recap: Arrowhead Pharma Q1 Earnings ↗

February 06, 2024

Via Benzinga

7 Biotech Stocks to Buy as Sector Rotation Ramps Up ↗

March 13, 2024

The Russell 2000 is up about 4% year to date, and could push higher, taking the most undervalued Russell 2000 stocks along for the ride.

The 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024 ↗

March 11, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday ↗

March 11, 2024

Via Benzinga

Topics Stocks

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy

March 08, 2024

Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.

Earnings Scheduled For February 6, 2024 ↗

February 06, 2024

Via Benzinga

4 Analysts Assess Arrowhead Pharma: What You Need To Know ↗

January 02, 2024

Via Benzinga

Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences

March 04, 2024

Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday ↗

March 01, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.

Via Benzinga

Topics Stocks

7 Oversold Russell 2000 Stocks to Add to Your February Buy List ↗

February 25, 2024

Investors may want to jump into oversold Russell 2000 stocks. After a rough outing in 2023, many are starting to come back strong.

Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.

Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗

February 23, 2024

Via Investor's Business Daily

7 Biotech Stocks Fighting America’s Deadliest Diseases ↗

February 08, 2024

Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship.

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 06, 2024

Via Benzinga

Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results

February 06, 2024

Arrowhead Pharmaceuticals to Webcast Fiscal 2024 First Quarter Results

January 22, 2024

Arrowhead Pharmaceuticals Closes Underwritten Offering with Gross Proceeds of $450.0 Million

January 05, 2024

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Via Investor's Business Daily

Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday ↗

January 04, 2024

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following...

Via Benzinga

Topics Stocks

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 03, 2024

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.

Via Benzinga

Why Arrowhead Pharmaceuticals Shares Are Moving ↗

January 03, 2024

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) shares are trading higher by 5.4% to $32.68, gaining after initially falling, after the company priced an underwritten registered offering of about 15.79...

Via Benzinga

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

January 03, 2024

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a...

Via Benzinga

Topics Stocks

Arrowhead Pharmaceuticals Announces Pricing of $450.0 Million Underwritten Offering of Common Stock

January 03, 2024

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

December 29, 2023

Piper Sandler sees potential turnaround for Biotech sector in 2024, identifies thee top stocks; Arrowhead, Legend Biotech & Alnylam Pharmaceuticals.

Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback ↗

December 29, 2023

Via Benzinga

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-CFB for Complement Mediated Kidney Disease

December 21, 2023